Add to ORKGNew drugs are regularly introduced for treatment, diagnosis or prevention of diseases. Adverse drug reactions (ADR) can be seen in clinical practice with both new as well as marketed medicines. Spontaneous reporting of ADR is commonly practiced method for monitoring of ADR. Healthcare practitioners have an important role in pharmacovigilance and ADR reporting. Many studies have been conducted to understand the knowledge, attitude and practice of ADR reporting among healthcare practitioners in India. The population surveyed in these studied ranged between 90-1200. One large study4 included population of 1200 physicians across India out of which 1000 were contacted for study participation
Background: The objective of the study was to study the clinical patterns, causality and severity of...
Background: Pharmacovigilance and adverse drug reactions monitoring has become an integral part to e...
Background: There has been a rapid increase in the number of drugs entering the market from last few...
Background: Adverse drug reactions (ADR) are more commonly observed during treatment course in a sub...
Background: Adverse drug reactions (ADRs) are the major cause of drug related morbidity and mortalit...
Background: Adverse drug reactions (ADRs) are major worldwide public health problem. Proper reportin...
Background: Pharmacovigilance has evolved as an important tool for dealing with Adverse Drug Reactio...
Background: No pharmacotherapeutic agent is completely free from noxious and unintended effects and ...
Background: Underreporting of ADRs still remains a major obstacle in the complete success of pharmac...
The present pilot study aims to compare the knowledge pertaining to ADR reporting systems that gover...
The present pilot study aims to compare the knowledge pertaining to ADR reporting systems that gover...
Pharmacovigilance is a method of quick detection andreporting, of adverse drug reactions and adverse...
Background: The objective of the present study was to assess knowledge, attitude and practice of adv...
Background: Adverse drug reactions (ADRs) represent a serious health problem. Effective generation o...
Background: In general, adverse drug reactions (ADRs) are global problems causing both morbidity and...
Background: The objective of the study was to study the clinical patterns, causality and severity of...
Background: Pharmacovigilance and adverse drug reactions monitoring has become an integral part to e...
Background: There has been a rapid increase in the number of drugs entering the market from last few...
Background: Adverse drug reactions (ADR) are more commonly observed during treatment course in a sub...
Background: Adverse drug reactions (ADRs) are the major cause of drug related morbidity and mortalit...
Background: Adverse drug reactions (ADRs) are major worldwide public health problem. Proper reportin...
Background: Pharmacovigilance has evolved as an important tool for dealing with Adverse Drug Reactio...
Background: No pharmacotherapeutic agent is completely free from noxious and unintended effects and ...
Background: Underreporting of ADRs still remains a major obstacle in the complete success of pharmac...
The present pilot study aims to compare the knowledge pertaining to ADR reporting systems that gover...
The present pilot study aims to compare the knowledge pertaining to ADR reporting systems that gover...
Pharmacovigilance is a method of quick detection andreporting, of adverse drug reactions and adverse...
Background: The objective of the present study was to assess knowledge, attitude and practice of adv...
Background: Adverse drug reactions (ADRs) represent a serious health problem. Effective generation o...
Background: In general, adverse drug reactions (ADRs) are global problems causing both morbidity and...
Background: The objective of the study was to study the clinical patterns, causality and severity of...
Background: Pharmacovigilance and adverse drug reactions monitoring has become an integral part to e...
Background: There has been a rapid increase in the number of drugs entering the market from last few...